AVP portfolio
The short answer
AVP has been named as an investor in 1 reported round worth about $25M in disclosed capital, backing WhiteLab Genomics. Most recent: WhiteLab Genomics (€23.2 million, 2026-10-06).
- Deals logged
- 1
- Companies
- 1
- Disclosed rounds
- $25M
- Top sector
- Health
Every deal on record
| Date | Company | Amount | Round | Source |
|---|---|---|---|---|
| 2026-10-06 | WhiteLab Genomics | €23.2 million | Series B | EU-Startups |
How this is measured
Deals come from public funding announcements, credited in the source column. Only investors named in reports are listed; nothing is estimated.